Movement Disorders, ISSN 0885-3185, 06/2015, Volume 30, Issue 7, pp. 1009 - 1009
Journal Article
Movement Disorders, ISSN 0885-3185, 06/2015, Volume 30, Issue 7, pp. 1009 - 1009
CLINICAL NEUROLOGY | Neuroprotective Agents - therapeutic use | Parkinson Disease - complications | Double-Blind Method | Cognition Disorders - etiology | Humans | Parkinson Disease - drug therapy | Cognition Disorders - drug therapy | Indans - therapeutic use | Parkinson's disease | Pharmaceutical industry | Analysis | Dementia
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2016
Abstract Dementia can occur in a substantial number of patients with Parkinson ' s disease with a point prevalence close to 30%. The cognitive profile is...
Neurology
Neurology
Journal Article
JAMA Neurology, ISSN 2168-6149, 12/2016, Volume 73, Issue 12, pp. 1433 - 1439
IMPORTANCE: Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) is a frequent cause of adult-onset leukodystrophy known to be...
HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY | CSF1R GENE | LEUKODYSTROPHY | INVOLVEMENT | BRAIN-STEM | SPECTRUM | CLINICAL NEUROLOGY | Leukoencephalopathies - genetics | Humans | Leukoencephalopathies - diagnostic imaging | Male | Leukoencephalopathies - physiopathology | Sequence Analysis, DNA | Exome | Young Adult | Magnetic Resonance Imaging | Alanine-tRNA Ligase - genetics | Pedigree | Adolescent | Microglia - pathology | Adult | Female | Mutation
HEREDITARY DIFFUSE LEUKOENCEPHALOPATHY | CSF1R GENE | LEUKODYSTROPHY | INVOLVEMENT | BRAIN-STEM | SPECTRUM | CLINICAL NEUROLOGY | Leukoencephalopathies - genetics | Humans | Leukoencephalopathies - diagnostic imaging | Male | Leukoencephalopathies - physiopathology | Sequence Analysis, DNA | Exome | Young Adult | Magnetic Resonance Imaging | Alanine-tRNA Ligase - genetics | Pedigree | Adolescent | Microglia - pathology | Adult | Female | Mutation
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 03/2017, Volume 374, pp. 26 - 31
Dementia can occur in a substantial number of patients with Parkinson's disease with a point prevalence close to 30%. The cognitive profile is characterized by...
Parkinson's disease | Dementia with Lewy Bodies | Cholinesterase inhibitors | Dementia | RISK | ALPHA-SYNUCLEIN | MILD COGNITIVE IMPAIRMENT | MENTAL DYSFUNCTION | NEUROSCIENCES | CLINICAL NEUROLOGY | SOCIETY TASK-FORCE | COHORT | WHITE-MATTER HYPERINTENSITIES | SYDNEY MULTICENTER | DIAGNOSTIC-CRITERIA | LEWY BODIES | Parkinson Disease - complications | Dementia - pathology | Dementia - complications | Dementia - drug therapy | Humans | Parkinson Disease - epidemiology | Dementia - epidemiology | Cholinesterase Inhibitors - therapeutic use | Alzheimer's disease | Delusions | Delusional disorder
Parkinson's disease | Dementia with Lewy Bodies | Cholinesterase inhibitors | Dementia | RISK | ALPHA-SYNUCLEIN | MILD COGNITIVE IMPAIRMENT | MENTAL DYSFUNCTION | NEUROSCIENCES | CLINICAL NEUROLOGY | SOCIETY TASK-FORCE | COHORT | WHITE-MATTER HYPERINTENSITIES | SYDNEY MULTICENTER | DIAGNOSTIC-CRITERIA | LEWY BODIES | Parkinson Disease - complications | Dementia - pathology | Dementia - complications | Dementia - drug therapy | Humans | Parkinson Disease - epidemiology | Dementia - epidemiology | Cholinesterase Inhibitors - therapeutic use | Alzheimer's disease | Delusions | Delusional disorder
Journal Article
The Tohoku Journal of Experimental Medicine, ISSN 0040-8727, 2012, Volume 228, Issue 3, pp. 189 - 196
Vitamin D3 is a neurosteroid that mediates its effects via the vitamin D receptor (VDR). The VDR gene is located on chromosome 12q13 and consists of 9 exons....
neurodegeneration | vitamin D receptor | haplotype | Alzheimer's disease | vitamin D | Vitamin D | Neurodegeneration | Haplotype | Vitamin D receptor | MEDICINE, RESEARCH & EXPERIMENTAL | NERVOUS-SYSTEM | PERFORMANCE | D DEFICIENCY | RISK | POLYMORPHISM | PREVALENCE | MEDICINE, GENERAL & INTERNAL | 1,25-DIHYDROXYVITAMIN D-3 RECEPTORS | AMYLOID-BETA | BRAIN | Genetic Association Studies | Humans | Genotype | DNA Primers - genetics | Receptors, Calcitriol - genetics | Case-Control Studies | Haplotypes - genetics | Polymorphism, Restriction Fragment Length | Polymerase Chain Reaction | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Aged | Alzheimer Disease - genetics
neurodegeneration | vitamin D receptor | haplotype | Alzheimer's disease | vitamin D | Vitamin D | Neurodegeneration | Haplotype | Vitamin D receptor | MEDICINE, RESEARCH & EXPERIMENTAL | NERVOUS-SYSTEM | PERFORMANCE | D DEFICIENCY | RISK | POLYMORPHISM | PREVALENCE | MEDICINE, GENERAL & INTERNAL | 1,25-DIHYDROXYVITAMIN D-3 RECEPTORS | AMYLOID-BETA | BRAIN | Genetic Association Studies | Humans | Genotype | DNA Primers - genetics | Receptors, Calcitriol - genetics | Case-Control Studies | Haplotypes - genetics | Polymorphism, Restriction Fragment Length | Polymerase Chain Reaction | Aged, 80 and over | Polymorphism, Single Nucleotide - genetics | Aged | Alzheimer Disease - genetics
Journal Article
Neurobiology of aging, ISSN 0197-4580, 06/2019
"Presenilin 1" (PSEN1) gene mutations are the major known genetic cause of early-onset Alzheimer's disease. Herein, we report a novel heterozygous PSEN1...
Journal Article
Movement Disorders, ISSN 0885-3185, 07/2015, Volume 30, Issue 8, pp. 1130 - 1133
Background Recessive mutations in the F‐box protein 7 gene (FBXO7; PARK15) have been identified as a cause of the parkinsonian‐pyramidal syndrome. Here, we...
phenotype | Parkinson disease | FBXO7 gene | Turkey | autosomal‐recessive | autosomal-recessive | WHITE-MATTER LESIONS | FBXO7 | CLINICAL NEUROLOGY | Pedigree | Humans | Middle Aged | Aged, 80 and over | Female | Male | Consanguinity | Mutation | Parkinson Disease - genetics | Parkinson Disease - physiopathology | F-Box Proteins - genetics | Sleep | Parkinson's disease | Gene mutations | Analysis | Genes | Depression, Mental | Genetic research | Genetic aspects | Nucleotide sequencing | DNA sequencing
phenotype | Parkinson disease | FBXO7 gene | Turkey | autosomal‐recessive | autosomal-recessive | WHITE-MATTER LESIONS | FBXO7 | CLINICAL NEUROLOGY | Pedigree | Humans | Middle Aged | Aged, 80 and over | Female | Male | Consanguinity | Mutation | Parkinson Disease - genetics | Parkinson Disease - physiopathology | F-Box Proteins - genetics | Sleep | Parkinson's disease | Gene mutations | Analysis | Genes | Depression, Mental | Genetic research | Genetic aspects | Nucleotide sequencing | DNA sequencing
Journal Article
Molecular Biology Reports, ISSN 0301-4851, 4/2019, Volume 46, Issue 2, pp. 1701 - 1707
Numerous genetic evidence has pointed out that variations in cholesterol-related genes may be associated with an Alzheimer’s disease (AD) risk. We aimed to...
Life Sciences | Alzheimer’s disease | Animal Biochemistry | Risk | Animal Anatomy / Morphology / Histology | Cholesterol metabolism | Polymorphism | Linkage disequilibrium | Genes | Gene polymorphism | Cholesterol | Polymerase chain reaction | Genotype & phenotype | Genotyping | Apolipoprotein E | Alleles | Lipoprotein (low density) receptors | Alzheimer's disease | Age
Life Sciences | Alzheimer’s disease | Animal Biochemistry | Risk | Animal Anatomy / Morphology / Histology | Cholesterol metabolism | Polymorphism | Linkage disequilibrium | Genes | Gene polymorphism | Cholesterol | Polymerase chain reaction | Genotype & phenotype | Genotyping | Apolipoprotein E | Alleles | Lipoprotein (low density) receptors | Alzheimer's disease | Age
Journal Article
JAMA Neurology, ISSN 2168-6149, 01/2013, Volume 70, Issue 1, pp. 78 - 84
OBJECTIVE To identify new genes and risk factors associated with frontotemporal dementia (FTD). Several genes and loci have been associated with different...
NASU-HAKOLA-DISEASE | COMPLEX | CYSTS | PARKINSON DISEASE | ALS | TAU | VPS35 | DIAGNOSTIC-CRITERIA | HEXANUCLEOTIDE REPEAT | C9ORF72 | CLINICAL NEUROLOGY | Frontotemporal Dementia - genetics | Frontotemporal Dementia - physiopathology | Exome - genetics | Humans | Risk Factors | Adult | Male | Mutation - genetics | Receptors, Immunologic - genetics | Syndrome | Frontotemporal Dementia - pathology | Membrane Glycoproteins - genetics
NASU-HAKOLA-DISEASE | COMPLEX | CYSTS | PARKINSON DISEASE | ALS | TAU | VPS35 | DIAGNOSTIC-CRITERIA | HEXANUCLEOTIDE REPEAT | C9ORF72 | CLINICAL NEUROLOGY | Frontotemporal Dementia - genetics | Frontotemporal Dementia - physiopathology | Exome - genetics | Humans | Risk Factors | Adult | Male | Mutation - genetics | Receptors, Immunologic - genetics | Syndrome | Frontotemporal Dementia - pathology | Membrane Glycoproteins - genetics
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, p. e0162592
'Microtubule-associated protein tau' (MAPT), 'granulin' (GRN) and 'chromosome 9 open reading frame72' (C9ORF72) genemutations are the major known genetic...
HEXANUCLEOTIDE REPEAT EXPANSION | DIAGNOSIS | LOBAR DEGENERATION | RECOMMENDATIONS | TAU-MUTATIONS | MULTIDISCIPLINARY SCIENCES | NULL MUTATIONS | GUIDELINES | DISEASE | PROGRANULIN | ASSOCIATION | Frontotemporal Dementia - genetics | Blotting, Southern | Progranulins | Humans | Intercellular Signaling Peptides and Proteins - genetics | Male | Exome | Proteins - genetics | Turkey | tau Proteins - genetics | Pedigree | Polymerase Chain Reaction | Female | C9orf72 Protein | Mutation | Cohort Studies | RNA | Gene mutations | Genes | Genetic aspects | Nucleotide sequencing | Protein binding | DNA sequencing | Neurosciences | Disease | Laboratories | Nervous system | Proteins | FUS protein | Clonal deletion | Neurodegeneration | Deletion | Dementia disorders | Aging | Genetics | Chromosomes | Deoxyribonucleic acid--DNA | Sequences | Amyotrophic lateral sclerosis | Ribonucleic acid--RNA | Patients | Medicine | Granulin | Neurology | RNA-binding protein | Brain research | Gene frequency | Chromosome 9 | Frontotemporal dementia | Dementia | Deoxyribonucleic acid | Ribonucleic acid | DNA
HEXANUCLEOTIDE REPEAT EXPANSION | DIAGNOSIS | LOBAR DEGENERATION | RECOMMENDATIONS | TAU-MUTATIONS | MULTIDISCIPLINARY SCIENCES | NULL MUTATIONS | GUIDELINES | DISEASE | PROGRANULIN | ASSOCIATION | Frontotemporal Dementia - genetics | Blotting, Southern | Progranulins | Humans | Intercellular Signaling Peptides and Proteins - genetics | Male | Exome | Proteins - genetics | Turkey | tau Proteins - genetics | Pedigree | Polymerase Chain Reaction | Female | C9orf72 Protein | Mutation | Cohort Studies | RNA | Gene mutations | Genes | Genetic aspects | Nucleotide sequencing | Protein binding | DNA sequencing | Neurosciences | Disease | Laboratories | Nervous system | Proteins | FUS protein | Clonal deletion | Neurodegeneration | Deletion | Dementia disorders | Aging | Genetics | Chromosomes | Deoxyribonucleic acid--DNA | Sequences | Amyotrophic lateral sclerosis | Ribonucleic acid--RNA | Patients | Medicine | Granulin | Neurology | RNA-binding protein | Brain research | Gene frequency | Chromosome 9 | Frontotemporal dementia | Dementia | Deoxyribonucleic acid | Ribonucleic acid | DNA
Journal Article
Neurological Sciences, ISSN 1590-1874, 12/2013, Volume 34, Issue 12, pp. 2199 - 2204
Coeliac disease (CD) is an autoimmune disease of small intestine associated with sensitivity to gluten. The clinical manifestations are often of...
Neurology | Neurological involvement | White-matter | Medicine & Public Health | Cortical atrophy | Volumetry | Neurosurgery | Coeliac disease | Psychiatry | Neuroradiology | DIAGNOSIS | BRAIN ATROPHY | TRANSGLUTAMINASE | ABNORMALITIES | CEREBELLAR SYNDROME | NEUROSCIENCES | CLINICAL NEUROLOGY | GLUTEN ATAXIA | CHILDREN | WHITE-MATTER LESIONS | DISEASE | RATING-SCALE | Young Adult | Celiac Disease - pathology | Magnetic Resonance Imaging | Biopsy | Nerve Fibers, Myelinated - pathology | Humans | Middle Aged | Adolescent | Brain - pathology | Adult | Female | Male
Neurology | Neurological involvement | White-matter | Medicine & Public Health | Cortical atrophy | Volumetry | Neurosurgery | Coeliac disease | Psychiatry | Neuroradiology | DIAGNOSIS | BRAIN ATROPHY | TRANSGLUTAMINASE | ABNORMALITIES | CEREBELLAR SYNDROME | NEUROSCIENCES | CLINICAL NEUROLOGY | GLUTEN ATAXIA | CHILDREN | WHITE-MATTER LESIONS | DISEASE | RATING-SCALE | Young Adult | Celiac Disease - pathology | Magnetic Resonance Imaging | Biopsy | Nerve Fibers, Myelinated - pathology | Humans | Middle Aged | Adolescent | Brain - pathology | Adult | Female | Male
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2019, Volume 67, Issue 1, pp. 159 - 167
Progranulin (GRN) gene mutations are a major cause of frontotemporal dementia (FTD). Most mutations identified to date are null mutations, which are predicted...
progranulin | frontotemporal dementia | serum | splice site mutation | ELISA | PLASMA | GENETIC-VARIABILITY | ALZHEIMER | CONTRIBUTES | CARRIERS | NEUROSCIENCES | FAMILY | Proteins | Dementia disorders | Biomarkers | Bioindicators | mRNA | Mutation | Frontotemporal dementia | Dementia | Haploinsufficiency
progranulin | frontotemporal dementia | serum | splice site mutation | ELISA | PLASMA | GENETIC-VARIABILITY | ALZHEIMER | CONTRIBUTES | CARRIERS | NEUROSCIENCES | FAMILY | Proteins | Dementia disorders | Biomarkers | Bioindicators | mRNA | Mutation | Frontotemporal dementia | Dementia | Haploinsufficiency
Journal Article
Journal of Neurology, ISSN 0340-5354, 7/2015, Volume 262, Issue 7, pp. 1724 - 1727
Ataxia–telangiectasia (A-T) is an autosomal recessive inherited disease characterized by progressive childhood-onset cerebellar ataxia, oculomotor apraxia,...
Neurology | Neurosciences | Phenotype | Turkey | Medicine & Public Health | ATM | Dystonia | Neuroradiology | CLINICAL NEUROLOGY | Exome - genetics | Base Sequence | Humans | Middle Aged | Adult | Ataxia Telangiectasia - genetics | Family Health | Female | Male | Ataxia Telangiectasia Mutated Proteins - genetics | Mutation - genetics | Complications and side effects | Patient outcomes | Ataxia telangiectasia | Development and progression | Research | Risk factors
Neurology | Neurosciences | Phenotype | Turkey | Medicine & Public Health | ATM | Dystonia | Neuroradiology | CLINICAL NEUROLOGY | Exome - genetics | Base Sequence | Humans | Middle Aged | Adult | Ataxia Telangiectasia - genetics | Family Health | Female | Male | Ataxia Telangiectasia Mutated Proteins - genetics | Mutation - genetics | Complications and side effects | Patient outcomes | Ataxia telangiectasia | Development and progression | Research | Risk factors
Journal Article
NEUROLOGICAL SCIENCES, ISSN 1590-1874, 03/2015, Volume 36, Issue 3, pp. 411 - 413
Parkinson's disease (PD) is the second most common neurodegenerative disease, and its prevalence rate varies between 15 and 250/100.000. The data on the...
Population based | Parkinson's disease | Prevalence | Turkey | RISK | NEUROSCIENCES | CLINICAL NEUROLOGY | Rural Population - statistics & numerical data | Turkey - epidemiology | Humans | Middle Aged | Aged, 80 and over | Parkinson Disease - epidemiology | Female | Male | Aged | Medicine, Experimental | Medical research | Prevalence studies (Epidemiology)
Population based | Parkinson's disease | Prevalence | Turkey | RISK | NEUROSCIENCES | CLINICAL NEUROLOGY | Rural Population - statistics & numerical data | Turkey - epidemiology | Humans | Middle Aged | Aged, 80 and over | Parkinson Disease - epidemiology | Female | Male | Aged | Medicine, Experimental | Medical research | Prevalence studies (Epidemiology)
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2018, Volume 14, Issue 7, pp. P1468 - P1469
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2018, Volume 14, Issue 7, pp. P1467 - P1468
Journal Article
European Archives of Oto-Rhino-Laryngology, ISSN 0937-4477, 1/2019, Volume 276, Issue 1, pp. 139 - 142
To evaluate the olfactory function and the olfactory bulb (OB) volume changes in Wilson’s Disease (WD) patients.A prospective, controlled, single-blinded study...
Wilson’s disease | Olfactory dysfunction | Medicine & Public Health | Head and Neck Surgery | Olfaction | Olfactory bulb | Otorhinolaryngology | Neurosurgery
Wilson’s disease | Olfactory dysfunction | Medicine & Public Health | Head and Neck Surgery | Olfaction | Olfactory bulb | Otorhinolaryngology | Neurosurgery
Journal Article
Clinical Neurology and Neurosurgery, ISSN 0303-8467, 2010, Volume 113, Issue 1, pp. 11 - 13
Abstarct Objective and background Patients with Parkinson's disease may present with severe or intractable pain, which can be more distressing than the motor...
Neurology | Neurosurgery | Non-motor symptoms | Pain | Parkinson's disease | SURGERY | DIAGNOSIS | LEEDS ASSESSMENT | NEUROPATHIC SYMPTOMS | SCALE | CLINICAL NEUROLOGY | Parkinson Disease - complications | Prospective Studies | Pain - epidemiology | Levodopa - therapeutic use | Humans | Middle Aged | Anxiety - psychology | Male | Parkinson Disease - psychology | Antiparkinson Agents - therapeutic use | Pain - psychology | Psychiatric Status Rating Scales | Aged, 80 and over | Anxiety - complications | Depression - psychology | Pain - etiology | Adult | Depression - complications | Female | Aged | Pain Measurement
Neurology | Neurosurgery | Non-motor symptoms | Pain | Parkinson's disease | SURGERY | DIAGNOSIS | LEEDS ASSESSMENT | NEUROPATHIC SYMPTOMS | SCALE | CLINICAL NEUROLOGY | Parkinson Disease - complications | Prospective Studies | Pain - epidemiology | Levodopa - therapeutic use | Humans | Middle Aged | Anxiety - psychology | Male | Parkinson Disease - psychology | Antiparkinson Agents - therapeutic use | Pain - psychology | Psychiatric Status Rating Scales | Aged, 80 and over | Anxiety - complications | Depression - psychology | Pain - etiology | Adult | Depression - complications | Female | Aged | Pain Measurement
Journal Article
International Psychogeriatrics, ISSN 1041-6102, 02/2017, Volume 29, Issue 2, pp. 293 - 302
Background: Anosognosia is a common feature in Alzheimer's disease (AD). The brain substrates of anosognosia are not fully understood, and less is known about...
Alzheimer's disease | mild cognitive impairment | DEPRESSION | DEMENTIA | PSYCHIATRY | MEMORY DEFICITS | AWARENESS | PSYCHOLOGY, CLINICAL | PSYCHIATRIC-SYMPTOMS | PSYCHOLOGY | GERIATRICS & GERONTOLOGY | UNAWARENESS | FREQUENCY | SELF-APPRAISAL | GERONTOLOGY | ASSOCIATION | Agnosia - psychology | Alzheimer Disease - complications | Humans | Middle Aged | Cerebral Cortex - pathology | Memory, Episodic | Organ Size | Male | Cognition | Cerebral Cortex - diagnostic imaging | Neuropsychological Tests | Magnetic Resonance Imaging | Psychiatric Status Rating Scales | Turkey | Aged, 80 and over | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - complications | Executive Function | Alzheimer Disease - psychology | Nuclear magnetic resonance--NMR | Alzheimers disease | Memory | Questionnaires | Cognitive ability
Alzheimer's disease | mild cognitive impairment | DEPRESSION | DEMENTIA | PSYCHIATRY | MEMORY DEFICITS | AWARENESS | PSYCHOLOGY, CLINICAL | PSYCHIATRIC-SYMPTOMS | PSYCHOLOGY | GERIATRICS & GERONTOLOGY | UNAWARENESS | FREQUENCY | SELF-APPRAISAL | GERONTOLOGY | ASSOCIATION | Agnosia - psychology | Alzheimer Disease - complications | Humans | Middle Aged | Cerebral Cortex - pathology | Memory, Episodic | Organ Size | Male | Cognition | Cerebral Cortex - diagnostic imaging | Neuropsychological Tests | Magnetic Resonance Imaging | Psychiatric Status Rating Scales | Turkey | Aged, 80 and over | Cognitive Dysfunction - psychology | Female | Aged | Cognitive Dysfunction - complications | Executive Function | Alzheimer Disease - psychology | Nuclear magnetic resonance--NMR | Alzheimers disease | Memory | Questionnaires | Cognitive ability
Journal Article